Literature DB >> 8495425

Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression.

J A Moshier1, J Dosescu, M Skunca, G D Luk.   

Abstract

Ornithine decarboxylase (ODC) plays a rate-limiting role in polyamine biosynthesis and is intimately associated with cell proliferation and function. Although elevated levels of ODC mRNA, protein, and enzyme activity are consistently detected in transformed cells and tumors, the question remains as to whether ODC gene overexpression has a causative role in tumorigenesis. We have stably transfected NIH/3T3 fibroblasts with an expression construct containing human ODC complementary DNA under transcriptional control of the human beta-actin promoter. Cells transfected with the beta-actin/ODC DNA construct, designated NODC cells, and control transfectants, termed NLK cells, were analyzed for ODC gene expression and cell growth characteristics. ODC activity and mRNA levels were elevated 3-6-fold in NODC cells relative to NLK cells. NODC cells, in contrast to NLK control cells, are not contact inhibited, exhibit anchorage-independent growth, cycle more rapidly, and induce tumors in nude mice more efficiently and rapidly. These results directly establish a causative role for the misregulation of ODC gene expression in the acquisition of a transformation phenotype and provide a model to examine the interaction of ODC and other gene products in neoplastic development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495425

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Downregulation of ornithine decarboxylase by pcDNA-ODCr inhibits gastric cancer cell growth in vitro.

Authors:  Chun-xiao Xu; Yun-fei Yan; Ya-pei Yang; Bin Liu; Jia-xuan Xin; Shi-min Chen; Wei Wang; Chun-ying Jiang; Zhao-xin Lu; Xian-xi Liu
Journal:  Mol Biol Rep       Date:  2010-06-09       Impact factor: 2.316

2.  Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line.

Authors:  Enna Dogra Gupta; Manendra Pachauri; Prahlad Chandra Ghosh; Manchikatla Venkat Rajam
Journal:  Tumour Biol       Date:  2015-08-16

3.  The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.

Authors:  Anbarasu Kumaraswamy; Anitha Mamidi; Pavitra Desai; Ananthi Sivagnanam; Lakshmi Revathi Perumalsamy; Chandrasekaran Ramakrishnan; Michael Gromiha; Krishnaraj Rajalingam; Sundarasamy Mahalingam
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

4.  Phosphorylated human keratinocyte ornithine decarboxylase is preferentially associated with insoluble cellular proteins.

Authors:  M M Pomidor; R Cimildoro; B Lazatin; P Zheng; J A Gurr; I M Leigh; O A Jänne; R S Tuan; N J Hickok
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

5.  ATP-Dependent inactivation and sequestration of ornithine decarboxylase by the 26S proteasome are prerequisites for degradation.

Authors:  Y Murakami; S Matsufuji; S I Hayashi; N Tanahashi; K Tanaka
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.

Authors:  Amita Shukla-Dave; Mireia Castillo-Martin; Ming Chen; Jose Lobo; Nataliya Gladoun; Ana Collazo-Lorduy; Faisal M Khan; Vladimir Ponomarev; Zhengzi Yi; Weijia Zhang; Pier P Pandolfi; Hedvig Hricak; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2016-10-19       Impact factor: 4.307

Review 7.  Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma.

Authors:  Nicholas F Evageliou; Michael D Hogarty
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

8.  Regulation of all members of the antizyme family by antizyme inhibitor.

Authors:  Ursula Mangold; Ekkehard Leberer
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

9.  Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.

Authors:  M Auvinen; A Paasinen-Sohns; H Hirai; L C Andersson; E Hölttä
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

10.  Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression.

Authors:  S V Tavtigian; S D Zabludoff; B J Wold
Journal:  Mol Biol Cell       Date:  1994-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.